Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.32 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1952006 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL27449069 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL28485977 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| Ammonia Solution, Strong SCHEMBL11776045 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| Ammonia Solution, Strong SCHEMBL27570613 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL28365491 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL11763685 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL2521502 | 0.97 | TSHR (0.36) | TSHRCA2TDP1CA12CA14 | |
| SCHEMBL362990 | 0.89 | LMNA (0.45) | TSHR | |
| SCHEMBL28108587 | 0.88 | TSHR (0.38) | TSHRCA2CA12CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12624277-B2 | Injection fluids for stimulating fractured formations | CHEVRON U.S.A. INC. (US) | 2026-05-12 | — | — | US | claimed |
| US-20260098204-A1 | INJECTION FLUIDS COMPRISING AN ANIONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS | CHEVRON USA INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260055314-A1 | POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF | CHEVRON USA INC (US) | 2026-02-26 | — | — | US | claimed |
| US-20250354063-A1 | POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF | CHEVRON USA INC (US) | 2025-11-20 | — | — | US | claimed |
| US-12435262-B2 | Injection fluids comprising an anionic surfactant for treating unconventional formations | CHEVRON U.S.A. INC. (US) | 2025-10-07 | — | — | US | claimed |
| US-12331245-B2 | Use of a borate-acid buffer in oil and gas operations | CHEVRON U.S.A. INC. (US) | 2025-06-17 | — | — | US | claimed |
| US-12286588-B2 | Polyanionic surfactants and methods of making and using thereof | CHEVRON U.S.A. INC. (US) | 2025-04-29 | — | — | US | claimed |
| US-20240327698-A1 | INJECTION FLUIDS FOR STIMULATING FRACTURED FORMATIONS | CHEVRON U.S.A. INC. | 2024-10-03 | — | — | US | claimed |
| CN-115768852-B | Polyanionic surfactants and methods of making and using the same | 雪佛龙美国公司 | 2024-08-23 | — | — | CN | claimed |
| US-20240279532-A1 | INJECTION FLUIDS COMPRISING A NON-IONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS | CHEVRON U.S.A. INC. | 2024-08-22 | — | — | US | claimed |
| EP-0268324-A2 | Ion-pair complex conditioning agent and compositions containing same | THE PROCTER & GAMBLE COMPANY (US) | 1988-05-25 | — | — | EP | claimed |
| US-4540778-A | Sulfosuccinate, alkyl- and alkenyl sulfosuccinate, sulfomaleate, and disulfosuccinate half-esters of polygalactomannans | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1985-09-10 | — | — | US | claimed |
| US-4540807-A | SURFACTANTS FOR EMULSION POLYMERIZATION | WITCO CHEMICAL CORPORATION (US) | 1985-09-10 | — | — | US | claimed |
| US-4473489-A | ALKYLENE OXIDE SULFOSUCCINATES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1984-09-25 | — | — | US | claimed |
| EP-0103696-A2 | Aqueous surfactant concentrates and process for the flow behaviour of viscous aqueous surfactant concentrates | Henkel Kommanditgesellschaft auf Aktien (DE) | 1984-03-28 | — | — | EP | claimed |
| US-4379919-A | Starch sulfomaleate half-esters, a method for their preparation and their use to prepare starch disulfosuccinate half-esters | NATIONAL STARCH AND CHEMICAL CORPORATION (US) | 1983-04-12 | — | — | US | claimed |
| US-4179369-A | DEMULSIFYING, WHILE AGITATING, WITH AN ACRYLAMIDE POLYMER AND AN ETHOXYLATED AMINE OR ALCOHOL OR A SULFOSUCCINATE OR A SULFONATE SALT | NALCO CHEMICAL COMPANY (US) | 1979-12-18 | — | — | US | claimed |
| US-4169817-A | PROTEASE | MIDWEST BIOCHEMICAL CORPORATION (US) | 1979-10-02 | — | — | US | claimed |
| US-4169170-A | Control of dust during coal transportation | COMINCO LTD. (CA) | 1979-09-25 | — | — | US | claimed |
| US-3987093-A | PROCESS OF PRODUCING CARBOXYDISULFOSUCCINATES | CHEVRON RESEARCH COMPANY (US) | 1976-10-19 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260098204-A1 | INJECTION FLUIDS COMPRISING AN ANIONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS | PLA2G10, SOST, BCL2L10 | TSHR 3455/4885CA2 2460/4885TDP1 3302/4885 |
| US-20260055314-A1 | POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF | LPAR1, CCL11, OR10J3 | TSHR 709/4885CA2 625/4885TDP1 2305/4885 |
| US-12624277-B2 | Injection fluids for stimulating fractured formations | DEGS1, SCO2, F12 | TSHR 957/4885CA2 165/4885TDP1 3185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.